Yoeri Schrooten

602 total citations
24 papers, 385 citations indexed

About

Yoeri Schrooten is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Yoeri Schrooten has authored 24 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 18 papers in Virology and 5 papers in Hepatology. Recurrent topics in Yoeri Schrooten's work include HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (18 papers) and HIV/AIDS Research and Interventions (14 papers). Yoeri Schrooten is often cited by papers focused on HIV/AIDS drug development and treatment (21 papers), HIV Research and Treatment (18 papers) and HIV/AIDS Research and Interventions (14 papers). Yoeri Schrooten collaborates with scholars based in Belgium, Portugal and Cuba. Yoeri Schrooten's co-authors include Kristel Van Laethem, Anne–Mieke Vandamme, Eric Van Wijngaerden, Marc Van Ranst, Inge Derdelinckx, Paul De Munter, Philippe Lemey, Kris Covens, Joke Snoeck and Bart Maes and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Virology.

In The Last Decade

Yoeri Schrooten

23 papers receiving 381 citations

Peers

Yoeri Schrooten
Tiina Laukkanen Finland
Huamian Wei China
Dana N. Raugi United States
Eitel N. Mpoudi France
Daniele Armenia Italy
Pierre Bodelle United States
Christel Van den Eynde Belgium
Richard T. D'Aquila United States
Axel Fun Netherlands
Christian Tourrès France
Tiina Laukkanen Finland
Yoeri Schrooten
Citations per year, relative to Yoeri Schrooten Yoeri Schrooten (= 1×) peers Tiina Laukkanen

Countries citing papers authored by Yoeri Schrooten

Since Specialization
Citations

This map shows the geographic impact of Yoeri Schrooten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoeri Schrooten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoeri Schrooten more than expected).

Fields of papers citing papers by Yoeri Schrooten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoeri Schrooten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoeri Schrooten. The network helps show where Yoeri Schrooten may publish in the future.

Co-authorship network of co-authors of Yoeri Schrooten

This figure shows the co-authorship network connecting the top 25 collaborators of Yoeri Schrooten. A scholar is included among the top collaborators of Yoeri Schrooten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoeri Schrooten. Yoeri Schrooten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beuselinck, Kurt, David Bonsall, Rory Bowden, et al.. (2022). Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort. Journal of Clinical Virology. 155. 105252–105252. 3 indexed citations
2.
Cuypers, Lize, Pieter Libin, Yoeri Schrooten, et al.. (2017). Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning. Infection Genetics and Evolution. 53. 15–23. 9 indexed citations
3.
Cuypers, Lize, Nádia Conceição‐Neto, Yoeri Schrooten, et al.. (2017). A18 Random amplification with next-generation sequencing to cover HIV and HCV full-length genomes. Virus Evolution. 3(suppl_1). 1 indexed citations
4.
Cuypers, Lize, Bram Vrancken, Lavinia Fabeni, et al.. (2017). Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy. BMC Evolutionary Biology. 17(1). 70–70. 20 indexed citations
5.
Kourí, Vivian, Alina Álvarez, Jorge Pérez, et al.. (2015). Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba. PLoS ONE. 10(2). e0117176–e0117176. 7 indexed citations
6.
Vaira, Dolorès, Greet De Baets, Yoeri Schrooten, et al.. (2014). Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits. Virology. 456-457. 310–318. 5 indexed citations
7.
Kourí, Vivian, et al.. (2014). High frequency of antiviral drug resistance and non‐b subtypes in HIV‐1 patients failing antiviral therapy in Cuba. Journal of the International AIDS Society. 17(4S3). 19754–19754. 6 indexed citations
8.
Kourí, Vivian, Jorge Pérez, Yoeri Schrooten, et al.. (2013). Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba. Infection Genetics and Evolution. 16. 144–150. 23 indexed citations
9.
Schrooten, Yoeri, et al.. (2013). Evaluation of the automatic editing tool RECall for HIV-1 pol and V3 loop sequences. Journal of Virological Methods. 193(1). 135–139. 2 indexed citations
10.
Covens, Kris, Kabamba Kabeya, Yoeri Schrooten, et al.. (2009). Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes. Journal of Clinical Virology. 44(4). 325–328. 7 indexed citations
11.
Covens, Kris, Yoeri Schrooten, Jan Weber, et al.. (2009). Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs. Journal of Clinical Microbiology. 47(7). 2232–2242. 11 indexed citations
12.
Laethem, Kristel Van, Yoeri Schrooten, Kris Covens, et al.. (2008). A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes. Journal of Virological Methods. 153(2). 176–181. 48 indexed citations
13.
Laethem, Kristel Van, Paul De Munter, Yoeri Schrooten, et al.. (2007). No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: Impact of resistant minority variants on efficacy of low genetic barrier drugs. Journal of Clinical Virology. 39(1). 43–47. 32 indexed citations
14.
Lemey, Philippe, Sonia Van Dooren, Kristel Van Laethem, et al.. (2005). Molecular testing of multiple HIV-1 transmissions in a criminal case. AIDS. 19(15). 1649–1658. 32 indexed citations
15.
Laethem, Kristel Van, Yoeri Schrooten, Koen Deforche, et al.. (2005). A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes. Journal of Virological Methods. 132(1-2). 181–186. 15 indexed citations
16.
Snoeck, J., Chiara Riva, Kim Steegen, et al.. (2005). Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes. Journal of Virological Methods. 128(1-2). 47–53. 24 indexed citations
17.
Snoeck, Joke, Kristel Van Laethem, Philippe Hermans, et al.. (2004). Rising Prevalence of HIV-1 Non-B Subtypes in Belgium: 1983???2001. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(3). 279–285. 44 indexed citations
18.
Laethem, Kristel Van, Yoeri Schrooten, Philippe Lemey, et al.. (2004). A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene. Journal of Virological Methods. 123(1). 25–34. 42 indexed citations
19.
Maes, Bart, Yoeri Schrooten, Joke Snoeck, et al.. (2004). Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory. Journal of Virological Methods. 119(1). 45–49. 20 indexed citations
20.
Derdelinckx, Inge, Kristel Van Laethem, Bart Maes, et al.. (2003). Performance of the VERSANT®HIV-1 Resistance Assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes. FEMS Immunology & Medical Microbiology. 39(2). 119–124. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiina Laukkanen Breakdown of academic impact, for papers by Huamian Wei Breakdown of academic impact, for papers by Dana N. Raugi Breakdown of academic impact, for papers by Eitel N. Mpoudi Breakdown of academic impact, for papers by Daniele Armenia Breakdown of academic impact, for papers by Pierre Bodelle Breakdown of academic impact, for papers by Christel Van den Eynde Breakdown of academic impact, for papers by Richard T. D'Aquila Breakdown of academic impact, for papers by Axel Fun Breakdown of academic impact, for papers by Christian Tourrès
Rankless by CCL
2026